Alpha lipoic acid increases the formation of glutathione.
Is all ALA the same?
R-ALA is the form found naturally occurring within the body and is the biologically active form of alpha lipoic acid.
S-ALA is the unnatural, synthetic byproduct created during the production of alpha lipoic acid.
Nobody sells S-ALA by itself as it isn't very effective, but you will get S-ALA anytime you purchase ALA. The ALA you buy from nutrition stores is in reality a 50/50 mixture of S-ALA & R-ALA. (though they won't tell you that) Most companies don't go through the complicated and expensive process required to purify and remove the synthetic S-ALA from their products. Be aware that unless the bottle specifically states 100% R-ALA, you are only getting a 50/50 blend.
It is important for you to know that R-ALA has been shown time an time again to be up to 12 times as effective as S-ALA. There have been many studies, doctors and researchers who have stated how much more effective R-ALA is.
Is ALA Beneficial for Tick Borne Diseases?
Rickettsiae rickettsii (Rocky Mountain Spotted Fever) are gram negative rod shaped alphaproeobacteria, just like Bartonella are. Rickettsiae have a propensity to infect endothelial cells, just like bartonella do.
The use of ALA in conjunction with effective antimicrobials greatly increases cellular uptake resulting in killing the cellular infection.
The full study can be seen here.
The benefits of R-Lipoic Acid
· R-Lipoic acid is the only form of lipoic acid that is proven to significantly reduce inflammation, an underlying cause of aging.
· R-Lipoic acid is the only form of lipoic acid that is proven to significantly increase your cellular and mitochondrial antioxidant activity for preventing mitochondrial decay. This effectively attenuates the reported increase in oxidative stress with aging.
· R-Lipoic acid is the only form of lipoic acid that is proven to improve memory, reduce brain damage, reverse cognitive dysfunction, and protect the brain from neurodegeneration associated with aging.
· R-Lipoic acid is the only form of lipoic acid that is been proven to significantly increase insulin sensitivity, enhance glucose transport, increase metabolic rate and reduce the gain in body fat from aging.
· R-Lipoic acid is the only form of lipoic acid that is proven to protect body fats against oxidative damage, chelate harmful metals and reverse stress damage in your heart.
· R-Lipoic acid is the only form of Lipoic that is proven to significantly increase or maintain levels of other antioxidants including Coenzyme Q10, vitamin C, vitamin E and glutathione.
· R-Lipoic acid is the only form of Lipoic acid that is proven to expand total life span.
The problems of S-Lipoic acid
· S-Lipoic acid produces limited beneficial effects since it cannot bind with key enzymes.
· S-Lipoic acid is less effective than R-lipoic acid as an antioxidant.
· At high concentrations, S-Lipoic acid inhibits mitochondria metabolism and the antioxidant activity of R-lipoic acid.
· S-Lipoic acid is metabolized in the outer cell membrane. This may interfere with R-Lipoic acid's ability to penetrate the inner mitochondrial membrane and energy production.
· R-Lipoic acid costs slightly more per unit than alpha-Lipoic acid. But it may be 10 times stronger than regular alpha-Lipoic acid at reducing inflammation, a primary cause of aging. And it is free of the problems from the S-form.
This is a simple explaination of why R-ALA is much more effective than ALA.
What Conditions Could Benefit from ALA?
Alpha lipoic acid is thought to work as an antioxidant in both water and fatty tissue, enabling it to enter all parts of the nerve cell and protect it from damage.
Alpha lipoic acid can cross the blood-brain barrier, a wall of tiny vessels and structural cells, and pass easily into the brain. It is thought to protect brain and nerve tissue by preventing free radical damage.
As an antioxidant, alpha lipoic acid can neutralize free radicals which can damage cells. Free radical damage is thought to contribute to aging and chronic illness.
Lipoic acid was found to offer notable protection against cataract formation in an experimental animal model. Scientists believe that lipoic acid may confer this benefit by increasing levels of essential endogenous antioxidant enzymes such as glutathione peroxidase.
A study in patients with open-angle glaucoma found that visual function and other measures of glaucoma were improved in a group that received either 75 mg of lipoic acid daily for two months or 150 mg of lipoic acid daily for one month, compared with a control group that received no lipoic acid.
Investigators found that lipoic acid supplementation improved a variety of inflammatory measures that are associated with the disease. Further evidence also showed that lipoic acid supplementation produced improvements in animals suffering from an experimentally induced form of multiple sclerosis.
Researchers have identified a series of mechanisms through which lipoic acid may work in helping prevent or manage Alzheimer’s disease. Scientists believe that lipoic acid may increase the production of acetylcholine, an essential nervous system messenger that is deficient in the brains of Alzheimer’s disease victims.
Diabetes & Diabetic neuropathy
According to a just-released review of experimental studies, lipoic acid can help relieve several components of metabolic syndrome—a constellation of risk factors that often precedes full-blown types 2 diabetes. This review revealed that lipoic acid reduces blood pressure and insulin resistance, improves the lipid profile, and reduces weight. Scientists are encouraged by lipoic acid’s potential as a therapeutic agent for individuals with metabolic syndrome.
It has been found effective in the treatment of diabetic neuropathy, a type of nerve damage that occurs as a result of the toxic effects of high glucose levels on the nervous system in diabetes. Diabetic neuropathy is characterized by numbness, tingling, and pain best described as “burning” in the extremities.
Lipoic acid may also protect the body against toxic metal contaminants found in the environment and food supply. This multifunctional agent works by chelating these dangerous agents, such as arsenic, cadmium, lead, and mercury and rendering them inactive so that they can be removed by the body. In animal studies, lipoic acid has been shown to provide protection against arsenic poisoning and to safeguard the liver against the effects of cadmium exposure. Another study also showed that lipoic acid helped protect the delicate nervous system against the harmful effects of mercury poisoning.
Preliminary evidence suggests that lipoic acid could offer welcome relief for migraine sufferers. When a group of these individuals received a supplement of 600 mg of lipoic acid each day for three months, the frequency and intensity of their migraines declined modestly, and they also reported suffering fewer headache days.
Lipoic acid’s powerful antioxidant, anti-inflammatory, and lipid-lowering capabilities make it an ideal, multi-targeted nutrient for reducing cardiovascular risk. Lipoic acid helps protect the endothelium, the delicate, one-cell-thick lining of blood vessels. Additionally, lipoic acid improves blood vessels’ ability to relax, helping to lower blood pressure, improve blood flow, and reduce risk for cardiovascular events such as heart attack and stroke.
Cancer scientists are growing increasingly interested in lipoic acid because cancer cells offer many targets for its anti-inflammatory attributes. These attributes allow lipoic acid to intervene at multiple points in the chain of carcinogenesis. In experimental studies, lipoic acid shows promise against cancers of the blood (leukemia), lung, breast, and liver. Preliminary research indicates that lipoic acid acts to halt the cell reproductive cycle of cancer cells, slowing or stopping tumor growth. Lipoic acid may also help induce apoptosis, the programmed cell death that is the body’s natural control mechanism for weeding out nascent cancers. Lipoic acid also protects against chemical-induced DNA damage that can lead to cancerous transformation. Lipoic acid may help prevent metastatic cancer spread by reducing activity of enzymes that tumors use to invade tissues.
Restless leg syndrome
Protection Against Oxidative Stress
High blood pressure
The benefits of ALA are too numerous to cover in this post. As you can see there could be volumes written on this subject. If you are suffering with any tick borne infection it is definitely worth looking in to.
*** Remember to always check with your Dr before taking anything new, and check for any interactions with your current medications***
Holmquist L, Stuchbury G, Berbaum K, Muscat S, Young S, Hager K, Engel J, Münch G. Lipoic acid as a novel treatment for Alzheimer's disease and related dementias. Pharmacology & Therapeutics. 113.1 (2007): 154-164.
Takeuchi Y, Miyamoto T, Kakizawa T, Shigematsu S, Hashizume K. Insulin Autoimmune Syndrome possibly caused by alpha lipoic acid. Intern Med. 46.5 (2007): 237-239.
Ziegler D, Ametov A, Barinov A, Dyck PJ, Gurieva I, Low PA, Munzel U, Yakhno N, Raz I, Novosadova M, Maus J, Samigullin R. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes Care. 19.11 (2006): 2365-2370.
Packer L, Witt EH, Tritschler HJ. Alpha-lipoic acid as a biological antioxidant. Free Rad Biol Med 1995;19:227-250
Ou P, Tritschler HJ, Wolff SP. Thioctic (lipoic) acid: a therapeutic metal-chelating antioxidant? Biochem Pharmacol 1995; 50:123-126.
Hagen et al, "(R)-alpha-Lipoic acid-supplemented Old Rats Have Improved Mitochondrial Function, Decreased Oxidative Damage, and Increased Metabolic Rate," FASEB J 1999 13:411-418
Freisleben HJ, Neeb A, Lehr F, Ackermann H. Influence of selegiline and lipoic acid on the life expectancy of immunosuppressed mice. Arzneimittelforschung 1997 Jun; 47(6): 776-80
Ulrich H, Weischer CH, et al. Pharmaceutical composition containing R-.alpha.-lipoic acid or S-.alpha.-lipoic acid as active ingredient. US Patent 5,728,735, 1998.
Hagen et al, op. cit.
Suh JH, et al, Oxidative stress in the aging rat heart is reversed by dietary supplementation with (R)-(alpha)-lipoic acid. FASEB J 2001 Mar; 15(3): 700-6
Liu J, Head E, Gharib AM, et al, Memory loss in old rats is associated with brain mitochondrial decay and RNA/DNA oxidation: partial reversal by feeding acetyl-L-carnitine and/or R-alpha -lipoic acid. Proc Natl Acad Sci U S A 2002 Feb 19; 99(4): 2356-61
Hager K, Marahrens A, Kenklies M, et al, Alpha-lipoic acid as a new treatment option for Azheimer type dementia. Arch Gerontology Geriatric 2001 Jun; 32(3): 275-282
Jacob S, Rues P, Hermann R. Oral administration of RAC-alpha-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a placebo-controlled pilot trial. Free Rad Biol Med 1999 Aug;27(3-4):309-14
Moines H, Trios O, Park YC, Chow KJ, Packer L R-alpha-Lipoic Acid Action on Cell Redox Status, the Insulin Receptor, and Glucose Uptake in 3T3-L1 Adipocytes. . Arch Biochem Biophys 2002 Jan 15; 397(2): 384-91.
Suh JH, Shigeno ET, Morrow JD, Cox B, Rocha AE, Frei B, Hagen TM. Oxidative stress in the aging rat heart is reversed by dietary supplementation with (R)-(alpha)-lipoic acid. FASEB J 2001 Mar; 15(3): 700-6
Androne L, Gavan NA, Veresiu IA, Orasan R, In vivo effect of lipoic acid on lipid peroxidation in patients with diabetic neuropathy. In Vivo 2000 Mar-Apr; 14(2): 327-30
Suh JH, Shigeno ET, et al, Oxidative stress in the aging rat heart is reversed by dietary supplementation with (R)-(alpha)-lipoic acid. FASEB J 2001 Mar; 15(3): 700-615. Lykkesfeldt J, et al, Ames BN. Age-associated decline in ascorbic acid concentration, recycling, and biosynthesis in rat hepatocytes--reversal with (R)-alpha-lipoic acid supplementation. FASEB J 1998 Sep; 12(12): 1183-9
Streeper RS, Henriksen EJ, et al, Tritschler HJ. Differential effects of lipoic acid stereoisomers on glucose metabolism in insulin-resistant skeletal muscle. Am J Physiol 1997 Jul; 273(1 Pt 1): E185-91
Freisleben HJ, Neeb A, Lehr F, Ackermann H. Influence of selegiline and lipoic acid on the life expectancy of immunosuppressed mice Arzneimittelforschung 1997 Jun; 47(6): 776-80
Haramaki N, Han D, Handelman GJ, Tritschler HJ, Packer L. Cytosolic and mitochondrial systems for NADH- and NADPH-dependent reduction of alpha-lipoic acid Free Radic Biol Med 1997; 22(3): 535-42
Maitra I, Serbinova E, et al. Stereospecific effects of R-lipoic acid on buthionine sulfoximine-induced cataract formation in newborn rats. Biochem Biophys Res commun 1996; 221:422-429.
Streeper RS, Henriksen EJ, et al, Differential effects of lipoic acid stereoisomers on glucose metabolism in insulin-resistant skeletal muscle. Am J Physiol 1997 Jul; 273(1 Pt 1): E185-91
M.S. Patel, et al, Stereospecific effects of lipoic acids on mammalian pyruvate dehydrogenase complex
Packer, L; Tritschler, H; Wessel K, Neuroprotection by the metabolic Antioxidant alpha Lipoic Acid. 1997 Free Rad Biol Med 22, Nos 1/2, 359-378
Available at: http://www.pdrhealth.com/drug_info/nmdrugprofiles/nutsupdrugs/alp_0159.shtml. Accessed July 16, 2007.
Available at: http://lpi.oregonstate.edu/infocenter/othernuts/la/
Da Ros R, Assaloni R, Ceriello A. Molecular targets of diabetic vascular complications and potential new drugs. Curr Drug Targets. 2005 Jun;6(4):503-9.
Ceriello A. New insights on oxidative stress and diabetic complications may lead to a “causal” antioxidant therapy. Diabetes Care. 2003 May;26(5):1589-96.
No authors listed. Alpha-lipoic acid. Monograph. Altern Med Rev. 2006 Sept;11(3):232-7.
Pershadsingh HA. Alpha-lipoic acid: physiologic mechanisms and indications for the treatment of metabolic syndrome. Expert Opin Investig Drugs. 2007 Mar;16(3):291-302.
McMackin CJ, Widlansky ME, Hamburg NM, et al. Effect of combined treatment with alpha-Lipoic acid and acetyl-L-carnitine on vascular function and blood pressure in patients with coronary artery disease. J Clin Hypertens.(Greenwich.). 2007 Apr;9(4):249-55.
Kamenova P. Improvement of insulin sensitivity in patients with type 2 diabetes mellitus after oral administration of alpha-lipoic acid. Hormones (Athens). 2006 Oct-Dec;5(4):251-8.
Ziegler D, Hanefeld M, Ruhnau KJ, et al. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study). Diabetologia. 1995 Dec;38(12):1425-33.
Ziegler D, Ametov A, Barinov A, et al. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes Care. 2006 Nov;29(11):2365-70.
Maitra I, Serbinova E, Trischler H, Packer L. Alpha-lipoic acid prevents buthionine sulfoximine-induced cataract formation in newborn rats. Free Radic Biol Med. 1995 Apr;18(4):823-9.
Filina AA, Davydova NG, Endrikhovskii SN, Shamshinova AM. Lipoic acid as a means of metabolic therapy of open-angle glaucoma. Vestn Oftalmol. 1995 Oct;111(4):6-8.
Komeima K, Rogers BS, Lu L, Campochiaro PA. Antioxidants reduce cone cell death in a model of retinitis pigmentosa. Proc Natl Acad Sci U S A. 2006 Jul 25;103(30):11300-5.
Packer L, Tritschler HJ, Wessel K. Neuroprotection by the metabolic antioxidant alpha-lipoic acid. Free Radic Biol Med. 1997;22(1-2):359-78.
Panigrahi M, Sadguna Y, Shivakumar BR, et al. alpha-Lipoic acid protects against reperfusion injury following cerebral ischemia in rats. Brain Res. 1996 Apr 22;717(1-2):184-8.
Holmquist L, Stuchbury G, Berbaum K, et al. Lipoic acid as a novel treatment for Alzheimer’s disease and related dementias. Pharmacol Ther. 2007 Jan;113(1):154-64.
Marracci GH, McKeon GP, Marquardt WE, et al. Alpha lipoic acid inhibits human T-cell migration: implications for multiple sclerosis. J Neurosci Res. 2004 Nov 1;78(3):362-70.
Marracci GH, Jones RE, McKeon GP, Bourdette DN. Alpha lipoic acid inhibits T cell migration into the spinal cord and suppresses and treats experimental autoimmune encephalomyelitis. J Neuroimmunol. 2002 Oct;131(1-2):104-14.
Koh JM, Lee YS, Byun CH, et al. Alpha-lipoic acid suppresses osteoclastogenesis despite increasing the receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio in human bone marrow stromal cells. J Endocrinol. 2005 Jun;185(3):401-13.
Ha H, Lee JH, Kim HN, et al. Alpha-Lipoic acid inhibits inflammatory bone resorption by suppressing prostaglandin E2 synthesis. J Immunol. 2006 Jan 1;176(1):111-7.
Kim HJ, Chang EJ, Kim HM, et al. Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha. Free Radic Biol Med. 2006 May 1;40(9):1483-93.
Muller L, Menzel H. Studies on the efficacy of lipoate and dihydrolipoate in the alteration of cadmium2+ toxicity in isolated hepatocytes. Biochim Biophys Acta. 1990 May 22;1052(3):386-91.
Anuradha B, Varalakshmi P. Protective role of DL-alpha-lipoic acid against mercury-induced neural lipid peroxidation. Pharmacol Res. 1999 Jan;39(1):67-80.
Magis D, Ambrosini A, Sandor P, Jacquy J, Laloux P, Schoenen J. A randomized double-blind placebo-controlled trial of thioctic acid in migraine prophylaxis. Headache. 2007 Jan;47(1):52-7.
Beitner H. Randomized, placebo-controlled, double blind study on the clinical efficacy of a cream containing 5% alpha-lipoic acid related to photoageing of facial skin. Br J Dermatol. 2003 Oct;149(4):841-9.